 |
 |
|
|
RESÚMENES NOVIEMBRE 2004 |
Other Neuropsychiatric Disorders & General Information
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Aleksandra Lalovic, Louise Merkens, Laura Russell, Geneviève
Arsenault-Lapierre, Malgorzata J.M. Nowaczyk, Forbes D. Porter, Robert D.
Steiner, and Gustavo Turecki
Am
J Psychiatry 161:2123-2126, November 2004
Factors
influencing the development and amelioration of suicidal thoughts in the
general population
Cohort study
D. Gunnell, R. Harbord, N. Singleton, R. Jenkins, G. Lewis
The British Journal of Psychiatry (2004) 185: 385-393
Alexander I. F. Simpson, Brian Mckenna, Andrew Moskowitz, Jeremy
Skipworth, Justin Barry-Walsh
The British Journal of Psychiatry (2004) 185: 394-398
Susan S. F. Gau, Andrew T. A. Cheng
The British Journal of Psychiatry (2004) 185: 422-428
Evangelia M. Tsapakis, Amlan Basu and
Katherine J. Aitchison
Advances in Psychiatric
Treatment (2004) 10: 455-465
Critical
relationship between sodium valproate dose and human teratogenicity: results of
the Australian register of anti-epileptic drugs in pregnancy
Frank J. Vajda,
Terence J. O'Brien, Alison Hitchcock, Janet Graham, Mark Cook, Cecilie Lander
and Mervyn J. Eadie
Journal of Clinical Neuroscience. Volume 11, Issue 8,
November 2004, Pages 854-858
The dopamine-4
receptor gene associated with binge eating and weight gain in women with
seasonal affective disorder: An evolutionary perspective
Robert D. Levitan,
Mario Masellis, Vincenzo S. Basile, Raymond W. Lam, Allan S. Kaplan, Caroline
Davis, Pierandrea Muglia, Bronwyn Mackenzie, Subi Tharmalingam, Sidney H.
Kennedy, Fabio Macciardi and James L. Kennedy
Biological Psychiatry. Volume 56, Issue 9, 1 November
2004, Pages 665-669
Attempted
suicide and self-injury in patients diagnosed with eating disorders
Daniel Stein, Lisa
R. R. Lilenfeld, Prudence C. Wildman and Marsha D. Marcus
Comprehensive Psychiatry. Volume 45, Issue 6,
November-December 2004, Pages 447-451
A
double-blind placebo-controlled trial of milnacipran in the treatment of
fibromyalgia.
Vitton O, Gendreau M,
Gendreau J, Kranzler J, Rao SG
Hum Psychopharmacol. 2004 Oct;19 Suppl 1:S27-35
Assessing cost-effectiveness - Mental health: Introduction to the study
and methods
Haby MM, Carter R, Mihalopoulos C, et al.
Aust N Z J Psychiatry 2004;38(8):569-578
MANFRED
M. FICHTER and NORBERT QUADFLIEG
Psychological Medicine (2004), 34:8:1395-1406
Role of Dopaminergic Treatment in Dopamine Receptor
Down-regulation in Advanced Parkinson Disease. A Positron
Emission Tomographic Study
Stéphane
Thobois, François Vingerhoets, Valerie Fraix, Jing Xie-Brustolin, Hélène
Mollion, Nicolas Costes, Patrick Mertens, Alim-Louis Benabid, Pierre Pollak,
Emmanuel Broussolle
Arch Neurol. 2004;61:1705-1709
Laura
Solomon, William C. Reeves
Arch Intern Med. 2004;164:2241-2245
Cognitive
deterioration in Alzheimer’s disease: is the early course predictive of the
later stages?
E. Capitani,
R. Cazzaniga, A. Francescani and H. Spinnler
Neurological Sciences 2004; Volume 25, Number
4: 198 - 204
Psychiatric
diagnoses in 3275 suicides: a meta-analysis
Genevieve
Arsenault-Lapierre, Caroline D Kim and Gustavo Turecki
BMC Psychiatry 2004, 4:37
On
the potential role of glutamate transport in mental fatigue
Lars
Ronnback and Elisabeth Hansson
Journal of Neuroinflammation 2004, 1:22
A phase I trial of olanzapine (Zyprexa) for the prevention of delayed
emesis in cancer patients: A Hoosier oncology group study.
Passik SD, Navari RM, Jung S-H, et al.
Cancer Invest 2004;22(3):383-388
Comparison of the efficacy of new and conventional antipsychotic drugs
in the treatment of behavioral and psychological symptoms of dementia (BPSD)
Gareri P, Cotroneo A, Lacava R, et al.
Arch Gerontol Geriatr Suppl 2004;-(9):207-215
The management of psychogeriatric patient
Zannino G, Gargiulo A, Lamenza F, et al.
Arch Gerontol Geriatr Suppl 2004;-(9):465-470
Age and gender
effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome
P450 3A substrate
David J.
Greenblatt, Jerold S. Harmatz, Lisa L. von Moltke, C.Eugene Wright and Richard
I. Shader
Clinical Pharmacology & Therapeutics. Volume 76,
Issue 5,
November 2004, Pages 467-479
Don
L. Goldenberg, Carol Burckhardt, Leslie Crofford
Nicole C.
Barbarich, Claire W. McConaha, Jill Gaskill, Maria La Via, Guido K. Frank,
Sarah Achenbach, Katherine H. Plotnicov, and Walter H. Kaye
J Clin Psychiatry 2004;65:1480-1482
The
Use of Haloperidol and Associated Complications in the Agitated, Acutely Ill
Pediatric Burn Patient.
Ratcliff SL, Meyer WJ 3rd,
Cuervo LJ, Villarreal C, Thomas CR, Herndon DN